Llera, A.
Brammer, M.
Oakley, B.
Tillmann, J.
Zabihi, M.
Amelink, J. S.
Mei, T.
Charman, T.
Ecker, C.
Dell’Acqua, F.
Banaschewski, T.
Moessnang, C.
Baron-Cohen, S.
Holt, R.
Durston, S.
Murphy, D.
Loth, E.
Buitelaar, J. K.
Floris, D. L.
Beckmann, C. F.
Funding for this research was provided by:
Horizon 2020 Framework Programme (847818, 115300, 115300, 115300, 777394, 847818, 777394, 115300, 115300, 115300, 115300, 115300, 115300, 115300, 115300, 115300, 115300, 115300, 847818, 847818)
HORIZON EUROPE European Research Council (319456, 319456)
H2020 Marie Skłodowska-Curie Actions (101025785)
Netherlands Organization for Scientific Research (17854)
Wellcome Collaborative Award (215573)
Article History
Received: 10 February 2022
Accepted: 2 June 2022
First Online: 16 August 2022
Declarations
:
: This study research, and all methods involved, were performed according to the regulations and guidelines defined by the Declaration of Helsinki. The experimental protocol was approved by the ethical licensing committee CMO Arnhem/Nijmegen under approval number CMO2014/288. Informed consent was obtained from all subjects and/or their legal guardians.
: Not applicable.
: JKB has been a consultant to, advisory board member of, and a speaker for Takeda/Shire, Medice, Roche, and Servier. He is not an employee of any of these companies and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, or royalties. CFB is director and shareholder in SBGneuro Ltd. TC has received consultancy from Roche and Servier and received book royalties from Guildford Press and Sage. DM has been a consultant to, and advisory board member, for Roche and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. TB served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire, and Infectopharm. He received conference support or speaker’s fee by Lilly, Medice, and Shire. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. JT is a current full-time employee of F. Hoffmann–La Roche Ltd. The other authors report no biomedical financial interests or potential conflicts of interest.